Heparin opposes prostanoid and non-prostanoid platelet inhibitors by direct enhancement of aggregation
- 1 April 1981
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 22 (1-2) , 167-175
- https://doi.org/10.1016/0049-3848(81)90318-2
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Effect of Heparin and Heparin Fractions on Platelet AggregationJournal of Clinical Investigation, 1980
- Is prostacyclin a physiologically important circulating anti-platelet agent?Nature, 1980
- Heparin Neutralization of PGI 2 : Effects Upon PlateletsScience, 1979
- Heparin and dextran sulfate antagonize PGI2 inhibition of platelet aggregationThrombosis Research, 1979
- Effect of platelet activity of inhibition of adenylate cyclaseThrombosis Research, 1978
- Modulation of adenylate cyclase activity by sulfated glycosaminoglycans I. Inhibition by heparin of gonadotropin- stimulated ovarian adenylate cyclaseBiochimica et Biophysica Acta (BBA) - General Subjects, 1978
- Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMPBiochemical Journal, 1978
- Heparin-induced thrombocytopeniaArchives of internal medicine (1960), 1978
- Effects of prostacyclin (PGX) on cyclic AMP concentrations in human plateletsProstaglandins, 1977
- Stimulation of human platelet adenylate cyclase by prostaglandin D2Thrombosis Research, 1974